vs
Side-by-side financial comparison of Albemarle Corporation (ALB) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.0× Albemarle Corporation). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -29.0%, a 33.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 15.9%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $233.1M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 2.4%).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
ALB vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.5B |
| Net Profit | $-414.2M | $66.5M |
| Gross Margin | 13.9% | 90.5% |
| Operating Margin | -15.2% | 12.4% |
| Net Margin | -29.0% | 4.4% |
| Revenue YoY | 15.9% | 32.8% |
| Net Profit YoY | -650.1% | 143.8% |
| EPS (diluted) | $-3.88 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.4B | $929.2M | ||
| Q1 24 | $1.4B | $751.7M |
| Q4 25 | $-414.2M | $66.5M | ||
| Q3 25 | $-160.7M | $124.8M | ||
| Q2 25 | $22.9M | $94.3M | ||
| Q1 25 | $41.3M | $1.3M | ||
| Q4 24 | $75.3M | $-151.9M | ||
| Q3 24 | $-1.1B | $-121.3M | ||
| Q2 24 | $-188.2M | $-120.4M | ||
| Q1 24 | $2.4M | $-251.2M |
| Q4 25 | 13.9% | 90.5% | ||
| Q3 25 | 9.0% | 86.1% | ||
| Q2 25 | 14.8% | 87.5% | ||
| Q1 25 | 14.5% | 85.2% | ||
| Q4 24 | 11.2% | 85.8% | ||
| Q3 24 | -7.7% | 83.0% | ||
| Q2 24 | -0.7% | 85.1% | ||
| Q1 24 | 2.9% | 83.4% |
| Q4 25 | -15.2% | 12.4% | ||
| Q3 25 | -16.6% | 11.5% | ||
| Q2 25 | 3.6% | 6.7% | ||
| Q1 25 | 1.8% | 1.0% | ||
| Q4 24 | 0.4% | -7.0% | ||
| Q3 24 | -81.9% | -12.0% | ||
| Q2 24 | -34.4% | -11.5% | ||
| Q1 24 | -13.2% | -34.8% |
| Q4 25 | -29.0% | 4.4% | ||
| Q3 25 | -12.3% | 8.8% | ||
| Q2 25 | 1.7% | 7.2% | ||
| Q1 25 | 3.8% | 0.1% | ||
| Q4 24 | 6.1% | -13.5% | ||
| Q3 24 | -78.9% | -12.1% | ||
| Q2 24 | -13.2% | -13.0% | ||
| Q1 24 | 0.2% | -33.4% |
| Q4 25 | $-3.88 | $0.05 | ||
| Q3 25 | $-1.72 | $0.08 | ||
| Q2 25 | $-0.16 | $0.06 | ||
| Q1 25 | $0.00 | $0.00 | ||
| Q4 24 | $0.29 | $-0.10 | ||
| Q3 24 | $-9.45 | $-0.09 | ||
| Q2 24 | $-1.96 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | $3.2B | $836.4M |
| Stockholders' EquityBook value | $9.5B | $4.4B |
| Total Assets | $16.4B | $8.2B |
| Debt / EquityLower = less leverage | 0.33× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.5B | ||
| Q3 25 | $1.9B | $4.0B | ||
| Q2 25 | $1.8B | $2.8B | ||
| Q1 25 | $1.5B | $2.5B | ||
| Q4 24 | $1.2B | $2.6B | ||
| Q3 24 | $1.7B | $2.7B | ||
| Q2 24 | $1.8B | $2.6B | ||
| Q1 24 | $2.1B | $2.8B |
| Q4 25 | $3.2B | $836.4M | ||
| Q3 25 | $3.6B | — | ||
| Q2 25 | $3.6B | — | ||
| Q1 25 | $3.5B | — | ||
| Q4 24 | $3.5B | — | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.5B | — | ||
| Q1 24 | $3.5B | — |
| Q4 25 | $9.5B | $4.4B | ||
| Q3 25 | $10.0B | $4.1B | ||
| Q2 25 | $10.2B | $3.8B | ||
| Q1 25 | $10.0B | $3.5B | ||
| Q4 24 | $10.0B | $3.3B | ||
| Q3 24 | $10.2B | $3.4B | ||
| Q2 24 | $11.2B | $3.4B | ||
| Q1 24 | $11.5B | $3.4B |
| Q4 25 | $16.4B | $8.2B | ||
| Q3 25 | $17.1B | $7.6B | ||
| Q2 25 | $17.3B | $6.3B | ||
| Q1 25 | $17.0B | $5.8B | ||
| Q4 24 | $16.6B | $5.9B | ||
| Q3 24 | $17.5B | $5.8B | ||
| Q2 24 | $18.4B | $5.7B | ||
| Q1 24 | $19.0B | $5.7B |
| Q4 25 | 0.33× | 0.19× | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.31× | — | ||
| Q1 24 | 0.31× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $388.5M | $417.3M |
| Free Cash FlowOCF − Capex | $233.1M | $379.8M |
| FCF MarginFCF / Revenue | 16.3% | 25.4% |
| Capex IntensityCapex / Revenue | 10.9% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $692.5M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.5M | $417.3M | ||
| Q3 25 | $355.6M | $402.6M | ||
| Q2 25 | $-7.2M | $263.6M | ||
| Q1 25 | $545.4M | $44.1M | ||
| Q4 24 | $674.0K | $75.2M | ||
| Q3 24 | $240.5M | $188.4M | ||
| Q2 24 | $362.9M | $-95.6M | ||
| Q1 24 | $98.0M | $-308.6M |
| Q4 25 | $233.1M | $379.8M | ||
| Q3 25 | $223.4M | $354.5M | ||
| Q2 25 | $-126.8M | $219.8M | ||
| Q1 25 | $362.8M | $-12.3M | ||
| Q4 24 | $-355.1M | $-17.3M | ||
| Q3 24 | $-62.6M | $54.7M | ||
| Q2 24 | $-84.7M | $-205.5M | ||
| Q1 24 | $-481.4M | $-465.1M |
| Q4 25 | 16.3% | 25.4% | ||
| Q3 25 | 17.1% | 25.1% | ||
| Q2 25 | -9.5% | 16.7% | ||
| Q1 25 | 33.7% | -1.1% | ||
| Q4 24 | -28.8% | -1.5% | ||
| Q3 24 | -4.6% | 5.5% | ||
| Q2 24 | -5.9% | -22.1% | ||
| Q1 24 | -35.4% | -61.9% |
| Q4 25 | 10.9% | 2.5% | ||
| Q3 25 | 10.1% | 3.4% | ||
| Q2 25 | 9.0% | 3.3% | ||
| Q1 25 | 17.0% | 5.0% | ||
| Q4 24 | 28.9% | 8.2% | ||
| Q3 24 | 22.4% | 13.3% | ||
| Q2 24 | 31.3% | 11.8% | ||
| Q1 24 | 42.6% | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | — | 3.22× | ||
| Q2 25 | -0.31× | 2.79× | ||
| Q1 25 | 13.19× | 34.71× | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 40.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALB
| Energy Storage | $759.1M | 53% |
| Specialties | $348.9M | 24% |
| Ketjen | $320.1M | 22% |
ONC
Segment breakdown not available.
